Wednesday, 16th November ESA-SRB-APEG-NZSE 2022

• Evolving diagnostic evaluation and classification of pituitary tumours - Nele F Lenders
• Aggressive Pituitary Tumours - identification and management - Ann McCormack
• Pituitary imaging for endocrinologists - diagnosis and follow-up - Warrick J Inder
• Prolactin-induced suppression of gonadotrophin secretion during lactation - Eleni CR Hackwell

• Immunotherapy: Where to from Here - Peter Shepherd
• Checkpoint inhibitor autoimmune diabetes - Jenny Gunton
• Beta cell replacement for type 1 diabetes - Thomas Kay
• CAR-T cell therapies for endocrine-related cancers - Renea Taylor

• Effective treatments for men with male-factor infertility. - Mark A Baker
• The application of reproductive engineering to manage the breeding stallion - Zamira Gibb
• New Generation of Mesh Technology for Prolapse Repair - Shayanti Mukherjee
• Improved high-throughput assay to detect endocrine-disrupting chemicals - Gerard A Tarulli

• Recombinant AAV-mediated liver-targeted dual adrenal enzyme gene delivery in a model for congenital adrenal hyperplasia - Lara Graves
• Development of islet autoimmunity in Australian children at-risk of type 1 diabetes in the Environmental Determinants of Islet Autoimmunity (ENDIA)  study - Jennifer Couper
• Precision medicine in intersex conditions through reprograming patient fibroblasts into testicular Sertoli-like cells - Vincent Harley
• Chemokine receptor expression of CD4+ T cells responding to proinsulin predicts remission duration in Type 1 Diabetes  - Yassmin Musthaffa
• National health care that does not fund continuous glucose monitoring drives inequity in Paediatric Diabetes: The New Zealand example. - Mercedes J Burnside

• Age-dependent loss of cohesin protection in human eggs - Bettina P Mihalas
• Connecting oocyte mitochondrial ultrastructure and function - Karen L Reader
• Dominant follicle selection in mice - Michael W Pankhurst
• The potential for transgenerational effects of endocrine disrupting chemicals on female ovarian development and reproductive health - Kate Fowler

• A pilot in vivo study:  potential ovarian cancer therapeutic by placental extracellular vesicles - Qi Chen
• Oocyte mitochondria as key regulators of follicle development - Deepak Adhikari
• Iodine and other factors associated with improved fertility following oil-soluble contrast medium hysterosalpingography - Divya Mathews
• Using single-cell RNA sequencing to determine granulosa cell mediated regulation of primordial follicle activation - Emily R Frost

Supported by:

• Defining the Impact of Endocrine Disruptors on Reproductive Health - Andrew Pask